{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Stillwater",
      "state": "MN",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "93741",
      "recalling_firm": "Diasorin Inc.",
      "address_1": "1951 Northwestern Ave S",
      "address_2": "N/A",
      "postal_code": "55082-7536",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Worldwide distribution - US Nationwide and the country of Canada.",
      "recall_number": "Z-0815-2024",
      "product_description": "DiaSorin LIAISON HSV-2 Type Specific IgG, REF 310620",
      "product_quantity": "31992 units",
      "reason_for_recall": "DiaSorin has identified that lots 136344, 136344A, 136344B, 136344C, 136520, 136520A, 136520B, 136520C, 136604, 136703, 136703A, 136703B, 136703C  136775of LIAISON HSV-2 Type Specific IgG assay may produce increased equivocal and/or false positive results.",
      "recall_initiation_date": "20231213",
      "center_classification_date": "20240125",
      "report_date": "20240131",
      "code_info": "UDI/DI 08056771600101, Lot Numbers:  136344, 136344A, 136344B, 136344C, 136520, 136520A, 136520B, 136520C, 136604, 136703, 136703A, 136703B, 136703C, 136775"
    }
  ]
}